Clinical Trial Update: A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing OROS hydromorphone hydrochloride with morphine for cancer-related pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Morphine (morphine)
• OROS Hydromorphone HCl (Hydromorphone hydrochloride)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Pain, Analgesics, Opioid | Phase 3 | Status: COMPLETED